Premium Research-Only Peptides

Cartalax

$44.00

- +

Cartalax is a proprietary peptide blend formulated for research into joint health, cartilage support, and connective tissue maintenance.

It is widely used in research models exploring mobility, joint function and structural integrity.

Cartalax combines peptides that target multiple pathways involved in joint health, cartilage support, and connective tissue integrity in research applications.

Cartalax (AED; Ala–Glu–Asp) is a synthetic tripeptide of the Short Peptide Bioregulator family used in RUO models to probe gene-expression programs in connective-tissue cell types. Studies often quantify transcriptional readouts in Chondrocyte and Fibroblast cultures, Extracellular Matrix (ECM) synthesis markers, and peptide–DNA interaction models in vitro. Not intended for diagnostic or therapeutic use.

  • Gene-expression profiling in connective-tissue cell models
  • Extracellular Matrix synthesis-marker readouts
  • Comparative assays vs. control peptide sequences

Cartalax | Molecular Identity & Composition
Name Cartalax
Synonyms AED peptide; T-31; Ala-Glu-Asp
Sequence L-Ala–L-Glu–L-Asp (AED)
Molecular Formula C12H19N3O8
Molecular Weight 333.3 g/mol
CAS Number Not Formally Assigned (PubChem CID 87815447)
Appearance White to off-white lyophilized powder
Solubility Freely soluble in sterile or bacteriostatic water
Purity ≥99% (HPLC), lot-specific
Storage Guidelines • Lyophilized: ≤0°F (–18°C), dry, protected from light
• Reconstituted: 36–46°F (2–8°C); avoid repeat freeze–thaw
• Long-Term: Keep dry and frozen until use


Ellixon Bio Quality Advantage
  • Purity & Identity: ≥99% | HPLC & MS validated
  • Endotoxin & Sterility: <0.05 EU/mg | Third-party verified
  • Stability & Process: Controlled nucleation lyophilization | Stability-focused procedures
  • Formulation & QA: PhD-Formulated | GMP / ISO-Aligned manufacturing
  • Packaging: Luxe Fridge-Ready Box

Category Overview | Short Peptide Bioregulators

Short Peptide Bioregulators are ultrashort sequences — typically two to four amino acids — used in RUO studies to explore tissue-selective activity in cell-culture and preclinical model systems. Rather than classical surface-receptor agonism, this family is examined for proposed interactions with chromatin and gene-promoter regions, making these peptides compact tools for probing how defined sequences influence transcriptional programs in specific cell types.

Exciting Areas of Study

  • Peptide–DNA interaction and gene-expression modeling.
  • Map bioregulator peptide effects on transcriptional programs.
  • Study Extracellular Matrix synthesis markers in tissue-model assays.
  • Investigate cell-senescence readouts in connective-tissue cultures.
  • Quantify sequence-specific responses across cell types

Cartalax | Research Modeling & Applications
  • Track gene-expression markers in Chondrocyte and Fibroblast cultures
  • Benchmark concentration–response across ECM-related reporters
  • Compare AED vs. control peptides in transcriptional assays

Research Use Disclaimer

This product is supplied for laboratory research use only (RUO) and is intended solely for qualified professionals in a controlled research setting. It is not a drug, food, dietary supplement, cosmetic, or medical device, and is not intended for human or veterinary use or for any diagnostic, therapeutic, or clinical application. It is not for household use.

No statement on this page has been evaluated by the U.S. Food and Drug Administration. Nothing herein is intended to diagnose, treat, cure, or prevent any disease, nor to suggest any dosage, route, or method of administration. Ellixon Bio makes no representation or warranty, express or implied, regarding fitness for any purpose other than research and provides no medical or professional advice. The purchaser and end user assume full responsibility for safe handling, storage, and use in accordance with all applicable laws, regulations, and institutional safety protocols, and accept all associated risk and liability.

See our Terms & Conditions and our Research Compliance Disclaimers for complete terms.

Lot numberStrengthAnalysis dateTestingCertificate
EBL-CAR-10-0726-0128-100110 MGAugust 9, 2026Purity & Net Peptide TestingView PDF
Scroll to Top